Atlas Trials

Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder

Clinical trial NCT06588010 · RECRUITING

Trial details

NCT number
NCT06588010
Sponsor
Centre Hospitalier Universitaire Dijon
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Neurogenic Bladder
Start date
2024-12-16
Primary completion
2027-12-01
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.